Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients
- PMID: 12773978
- DOI: 10.1067/msy.2003.147
Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients
Abstract
Background: The justification for surgical resection of liver metastases from gastric cancer remains controversial.
Methods: Twenty-two patients who underwent 26 hepatectomies for liver metastases of gastric cancer between 1985 and 2001 were analyzed. Fifteen clinicopathologic factors were evaluated with univariate and multivariate analyses for survival after hepatic resection.
Results: The overall 1-year, 3-year, and 5-year survival rates after hepatectomy for gastric metastases were 73%, 38%, and 38%, respectively. Five patients survived for more than 3 years without recurrence, 3 of whom had synchronous metastases resected at the time of gastrectomy. The best results after surgical resection for liver metastases of gastric cancer were obtained with solitary metastases less than 5 cm in size. The number of liver metastases (solitary or multiple) was the only significant prognostic factor according to both univariate and multivariate analyses.
Conclusion: Surgical resection for liver metastases of gastric cancer may be beneficial for patients with a solitary metastasis, whether it is synchronous or metachronous.
Similar articles
-
Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors.Jpn J Clin Oncol. 2007 Nov;37(11):836-42. doi: 10.1093/jjco/hym113. Epub 2007 Oct 10. Jpn J Clin Oncol. 2007. PMID: 17928333
-
Surgical management for metastatic liver tumors.Hepatogastroenterology. 2006 Sep-Oct;53(71):757-63. Hepatogastroenterology. 2006. PMID: 17086883
-
Prognostic studies on gastric cancer with concomitant liver metastases.Hepatogastroenterology. 2001 May-Jun;48(39):892-4. Hepatogastroenterology. 2001. PMID: 11462950
-
[Surgical treatment for colorectal liver metastases--results of multi-institute study for effects of radical hepatectomy].Gan To Kagaku Ryoho. 2004 May;31(5):690-4. Gan To Kagaku Ryoho. 2004. PMID: 15170974 Review. Japanese.
-
[Diagnosis and treatment of colorectal liver metastases - workflow].Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796. Zentralbl Chir. 2008. PMID: 18563694 Review. German.
Cited by
-
Hepatectomy Offers Superior Survival Compared with Non-surgical Treatment for ≤ 3 Metastatic Tumors with Diameters < 3 cm from Gastric Cancer: A Retrospective Study.World J Surg. 2015 Nov;39(11):2757-63. doi: 10.1007/s00268-015-3151-0. World J Surg. 2015. PMID: 26148522
-
Aidi Injection, a Traditional Chinese Medicine Injection, Could Be Used as an Adjuvant Drug to Improve Quality of Life of Cancer Patients Receiving Chemotherapy: A Propensity Score Matching Analysis.Integr Cancer Ther. 2019 Jan-Dec;18:1534735418810799. doi: 10.1177/1534735418810799. Epub 2018 Nov 27. Integr Cancer Ther. 2019. PMID: 30482065 Free PMC article.
-
Hepatectomy for liver metastases from gastric cancer: a systematic review.BMC Surg. 2017 Feb 13;17(1):14. doi: 10.1186/s12893-017-0215-0. BMC Surg. 2017. PMID: 28193210 Free PMC article.
-
Metachronous Liver Metastasis Resulting from Early Gastric Carcinoma after Subtotal Gastrectomy Following Endoscopic Resection: A Case Report.J Gastric Cancer. 2015 Jun;15(2):139-42. doi: 10.5230/jgc.2015.15.2.139. Epub 2015 Jun 30. J Gastric Cancer. 2015. PMID: 26161288 Free PMC article.
-
Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis.Chin Med J (Engl). 2015 Aug 20;128(16):2194-201. doi: 10.4103/0366-6999.162497. Chin Med J (Engl). 2015. PMID: 26265613 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical